Medication Adjustment Considerations


Program Content


  • SGLT2i in HF: Medication Adjustments
    Considerations for Medication Adjustments in Patients With Heart Failure Initiating or Currently Taking SGLT2 Inhibitors
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 13, 2023

    View Activity


cover img faculity

Lee R. Goldberg, MD, MPH, FACC, FAHA, FHFSA

Vice Chair of Medicine for Informatics
Section Chief, Advanced Heart Failure and Cardiac Transplant
Professor of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

Provided by

ProCE Banner


This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company